Amyris delivers high-performance alternatives to petroleum, plant and animal-based products across a wide range of consumer and industry segments. Our products offer customers a way to reduce environmental impact with No Compromise® in performance or availability. We are making better chemistry biologically.

Investor FAQs

 

Amyris is an integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. We genetically modify microorganisms, primarily yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into potentially thousands of target molecules.

Amyris’s first commercialization efforts were focused on a molecule called farnesene, which forms the basis for a wide range of products varying from specialty chemical applications such as cosmetics, perfumes and food ingredients, industrial lubricants, solvents and polymers, to transportation fuels such as diesel and jet fuels. We call these No Compromise® products because we design them to perform comparably to or better than currently available products with the advantage of more reliable supply. Information on the company's product offerings can be found on the following web site: http://www.amyris.com/en/products

Amyris trades on the NASDAQ under the ticker symbol AMRS.

Amyris was incorporated in July 2003.

5885 Hollis Street, Suite 100
Emeryville, CA 94608
Main Phone: (510) 450-0761
Main Fax: (510) 225-2645

Amyris' fiscal year ends December 31.

On September 27, 2010, Amyris priced 5,300,000 shares at $16.00 per share.

Morgan Stanley & Co. Incorporated, Goldman Sachs & Company, and J.P. Morgan Securities, Inc. acted as book-running managers for the offering and Banco Itaú and Stifel Nicolaus Weisel acted as co-managers for the offering.

Amyris does not currently have a direct stock purchase plan.

As a company that trades publicly on the NASDAQ, shares can be bought and sold through your registered representative.

No, Amyris does not offer a Dividend Reinvestment Plan.

All stockholder phone calls and correspondence should be directed to our Shareholder Relations Call Center at 1-800-468-9716, or if calling from outside the US at 1-651-450-4064.

Stockholder correspondence (including address changes and transfers) can be sent to:

Mail
Wells Fargo
Shareowner Services
PO Box 64874
St Paul , Minnesota 55164-0874

Overnight
Wells Fargo Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100

All stockholder phone calls and correspondence should be directed to our Shareholder Relations Call Center at 1-800-468-9716, or if calling from outside the US at 1-651-450-4064.

Stockholder correspondence (including address changes and transfers) can be sent to:

Mail
Wells Fargo
Shareowner Services
PO Box 64874
St Paul , Minnesota 55164-0874

Overnight
Wells Fargo Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100

All stockholder phone calls and correspondence should be directed to our Shareholder Relations Call Center at 1-800-468-9716, or if calling from outside the US at 1-651-450-4064.

Stockholder correspondence (including address changes and transfers) can be sent to:

Mail
Wells Fargo
Shareowner Services
PO Box 64874
St Paul , Minnesota 55164-0874

Overnight
Wells Fargo Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100

For investor-related questions please contact:

Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris 
investor@amyris.com
510-740-7481

Please submit your question using the form below.

* Indicates required field